ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
2.300
+0.200 (9.52%)
At close: Jul 23, 2025
9.52%
Market Cap31.51M
Revenue (ttm)10.57M
Net Income (ttm)-5.59M
Shares Out15.92M
EPS (ttm)-0.35
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,235
Average Volume5,688
Open2.480
Previous Close2.100
Day's Range2.300 - 2.480
52-Week Range1.500 - 5.950
Beta0.54
RSI53.34
Earnings DateAug 28, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2024, ODI Pharma AB's revenue was 22.29 million, an increase of 15880.34% compared to the previous year's 139,457. Losses were -568,059, -91.77% less than in 2023.

Financial Statements

News

There is no news available yet.